191 related articles for article (PubMed ID: 36950709)
1. Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis,
Hassan AS; Morsy NM; Aboulthana WM; Ragab A
RSC Adv; 2023 Mar; 13(14):9281-9303. PubMed ID: 36950709
[TBL] [Abstract][Full Text] [Related]
2. In vitro enzymatic evaluation of some pyrazolo[1,5-a]pyrimidine derivatives: Design, synthesis, antioxidant, anti-diabetic, anti-Alzheimer, and anti-arthritic activities with molecular modeling simulation.
Hassan AS; Morsy NM; Aboulthana WM; Ragab A
Drug Dev Res; 2023 Feb; 84(1):3-24. PubMed ID: 36380556
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Evaluation and Bioinformatics Analysis of Schiff Bases Bearing Pyrazole Scaffold as Bioactive Agents: Antioxidant, Anti-Diabetic, Anti-Alzheimer, and Anti-Arthritic.
Alkahtani HM; Almehizia AA; Al-Omar MA; Obaidullah AJ; Zen AA; Hassan AS; Aboulthana WM
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894604
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
5. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antioxidant activity and SAR study of novel spiro-isatin-based Schiff bases.
Sonmez F; Gunesli Z; Kurt BZ; Gazioglu I; Avci D; Kucukislamoglu M
Mol Divers; 2019 Nov; 23(4):829-844. PubMed ID: 30612259
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Biological Evaluation of New Cycloalkyl Fused Quinolines Tethered to Isatin Schiff Bases as Cholinesterase Inhibitors.
Macha B; Kulkarni R; Garige AK; Palabindala R; Akkinepally R; Garlapati A
Comb Chem High Throughput Screen; 2022; 25(1):167-186. PubMed ID: 33308120
[TBL] [Abstract][Full Text] [Related]
8. Synthesis,
Abdelazeem NM; Aboulthana WM; Hassan AS; Almehizia AA; Naglah AM; Alkahtani HM
Saudi Pharm J; 2024 May; 32(5):102025. PubMed ID: 38550332
[TBL] [Abstract][Full Text] [Related]
9. Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation.
Jaiswal S; Tripathi RKP; Ayyannan SR
Biomed Pharmacother; 2018 Nov; 107():1611-1623. PubMed ID: 30257379
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
11. Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease.
Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Grishchenko MV; Lushchekina SV; Astakhova TY; Serebryakova OG; Timokhina EN; Zhilina EF; Shchegolkov EV; Ulitko MV; Radchenko EV; Palyulin VA; Burgart YV; Saloutin VI; Bachurin SO; Richardson RJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768608
[TBL] [Abstract][Full Text] [Related]
12. Novel hybrids of thiazolidinedione-1,3,4-oxadiazole derivatives: synthesis, molecular docking, MD simulations, ADMET study,
Srinivasa MG; Paithankar JG; Saheb Birangal SR; Pai A; Pai V; Deshpande SN; Revanasiddappa BC
RSC Adv; 2023 Jan; 13(3):1567-1579. PubMed ID: 36712616
[TBL] [Abstract][Full Text] [Related]
13. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.
Thakral S; Singh V
Med Chem; 2019; 15(2):186-195. PubMed ID: 30251608
[TBL] [Abstract][Full Text] [Related]
14. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Potential Biological Activities of Pyrazole-Based Schiff Bases as Anti-Diabetic, Anti-Alzheimer's, Anti-Inflammatory, and Cytotoxic Agents:
Naglah AM; Almehizia AA; Al-Wasidi AS; Alharbi AS; Alqarni MH; Hassan AS; Aboulthana WM
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794225
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, Calculation and Biological Activity Studies Based on Privileged Coumarin Derivatives as Multifunctional Anti-AD Lead Compound.
Wang H; Su M; Shi X; Li X; Zhang X; Yang A; Shen R
Chem Biodivers; 2023 Jan; 20(1):e202200867. PubMed ID: 36461922
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM
Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, spectroscopic characterization, single crystal X-ray analysis, in vitro α-amylase inhibition assay, DPPH free radical evaluation and computational studies of naphtho[2,3-d]imidazole-4,9-dione appended 1,2,3-triazoles.
Devi M; Kumar P; Singh R; Sindhu J; Kataria R
Eur J Med Chem; 2023 Mar; 250():115230. PubMed ID: 36863227
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of pyrrolo[2,3-d]pyrimidine linked hybrids as α-amylase inhibitors: molecular docking, MD simulation, ADMET and antidiabetic screening.
Zala AR; Tiwari R; Naik HN; Ahmad I; Patel H; Jauhari S; Kumari P
Mol Divers; 2023 Jun; ():. PubMed ID: 37344700
[TBL] [Abstract][Full Text] [Related]
20. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
